U.S. House members ask Trump to probe Navalny poisoning, suggest sanctions
Reuters
Published Sep 08, 2020 01:12PM ET
Updated Sep 08, 2020 07:11PM ET
WASHINGTON (Reuters) - The Republican and Democratic leaders of the U.S. House of Representatives Foreign Affairs Committee called on President Donald Trump's administration on Tuesday to investigate the suspected poisoning of Russian opposition leader Alexei Navalny, suggesting sanctions might be necessary.
"If the Russian government is once again determined to have used a chemical weapon against one of its own nationals, additional sanctions should be imposed," Representatives Eliot Engel, the Democratic committee chairman, and Michael McCaul, the panel's top Republican, said in a letter to Trump.
Germany, where Navalny is in a hospital, has said Navalny was poisoned with a Soviet-style Novichok nerve agent and wants the perpetrators held to account. Russia has until now not opened a criminal investigation and said there is no evidence yet of a crime.
Navalny is the most popular and prominent opponent of President Vladimir Putin, and the German announcement that he was poisoned by a nerve agent has raised the possibility of further Western sanctions against Moscow.
The White House did not immediately respond to a request for comment on the letter. Trump said on Friday his administration had not yet seen proof that Navalny was poisoned.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.